Bioventus Inc. Weighted Average Number of Shares Outstanding, Diluted from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Bioventus Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2021 to Q3 2025.
  • Bioventus Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 27, 2025 was 68.8M shares, a 5.49% increase year-over-year.
  • Bioventus Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 64.5M shares, a 3.03% increase from 2023.
  • Bioventus Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 62.6M shares, a 2.05% increase from 2022.
  • Bioventus Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 61.4M shares, a 35% increase from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)

Bioventus Inc. Quarterly Weighted Average Number of Shares Outstanding, Diluted (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 68.8M +3.58M +5.49% Jun 29, 2025 Sep 27, 2025 10-Q 2025-11-04
Q2 2025 68.5M +4.48M +6.99% Mar 30, 2025 Jun 28, 2025 10-Q 2025-08-06
Q1 2025 66M +2.63M +4.15% Jan 1, 2025 Mar 29, 2025 10-Q 2025-05-06
Q4 2024 64.5M +1.9M +3.03% Sep 29, 2024 Dec 31, 2024 10-K 2025-03-11
Q3 2024 65.3M +2.43M +3.87% Jun 30, 2024 Sep 28, 2024 10-Q 2025-11-04
Q2 2024 64.1M +1.51M +2.41% Mar 31, 2024 Jun 29, 2024 10-Q 2025-08-06
Q1 2024 63.4M +1.26M +2.02% Jan 1, 2024 Mar 30, 2024 10-Q 2025-05-06
Q4 2023 62.6M +1.26M +2.05% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-11
Q3 2023 62.8M +1.15M +1.87% Jul 2, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 62.6M +1.08M +1.75% Apr 2, 2023 Jul 1, 2023 10-Q 2024-08-06
Q1 2023 62.1M +1.64M +2.71% Jan 1, 2023 Apr 1, 2023 10-Q 2024-05-07
Q4 2022 61.4M +15.9M +35% Oct 2, 2022 Dec 31, 2022 10-K 2025-03-11
Q3 2022 61.7M +19.8M +47.4% Jul 3, 2022 Oct 1, 2022 10-Q 2023-11-07
Q2 2022 61.5M +19.7M +47.1% Apr 3, 2022 Jul 2, 2022 10-Q 2023-08-08
Q1 2022 60.5M +18.7M +44.7% Jan 1, 2022 Apr 2, 2022 10-Q 2023-05-16
Q4 2021 45.5M Oct 3, 2021 Dec 31, 2021 10-K 2024-03-12
Q3 2021 41.8M Jul 4, 2021 Oct 2, 2021 10-Q 2022-11-21
Q2 2021 41.8M Apr 4, 2021 Jul 3, 2021 10-Q 2022-08-12
Q1 2021 41.8M Jan 1, 2021 Apr 3, 2021 10-Q 2022-05-11

Bioventus Inc. Annual Weighted Average Number of Shares Outstanding, Diluted (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 64.5M +1.9M +3.03% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 62.6M +1.26M +2.05% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 61.4M +15.9M +35% Jan 1, 2022 Dec 31, 2022 10-K 2025-03-11
2021 45.5M Jan 1, 2021 Dec 31, 2021 10-K 2024-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.